Basic Information
| RNALocate ID: | RLID:01001187 |
| RNA Symbol: | hsa-let-7a-5p |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-let-7a |
| RNA ID: | miRBase:MIMAT0000062 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001185 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001186 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001188 | Endoplasmic reticulum | HEK-293 cells | 26304123 |
| RLID:01001189 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001190 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001191 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001192 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001193 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:01001194 | Polysome | Human cervical cancer cell line (HeLa) | 25609084 |
| RLID:11000554 | Exosome | Human milk | 28688106 |
| RLID:11000555 | Exosome | Glioblastoma cells | 19011622 |
| RLID:11000556 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
| RLID:11000557 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000558 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000559 | Exosome | Renal cancer cells | 21670082 |
| RLID:11000560 | Exosome | Serum | 22427800 |
| RLID:11000561 | Exosome | Brain tissue | 23382797 |
| RLID:11000562 | Exosome | Plasma | 23663360 |
| RLID:11000563 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000564 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11000565 | Exosome | Plasma | 24937531 |
| RLID:11000566 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
| RLID:11000567 | Microvesicle | Plasma | 19002258 |
| RLID:11000568 | Microvesicle | Glioblastoma cells | 19011622 |
| RLID:11000569 | Microvesicle | Plasma | 23077538 |
| RLID:11000570 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000571 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000001 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Colon tissue|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000261 | Microvesicle | Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-let-7a-5p | Idiopathic pulmonary fibrosis | MNDR-E-MI-00423 |
| MNDR | hsa-let-7a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-00424 |
| MNDR | hsa-let-7a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-00425 |
| MNDR | hsa-let-7a-5p | Oral squamous cell carcinoma | MNDR-E-MI-00426 |
| MNDR | hsa-let-7a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-00427 |
| MNDR | hsa-let-7a-5p | Medulloblastoma | MNDR-E-MI-00428 |
| MNDR | hsa-let-7a-5p | B cell lymphoma of malt type | MNDR-E-MI-00429 |
| MNDR | hsa-let-7a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-00430 |
| MNDR | hsa-let-7a-5p | Lymphoma | MNDR-E-MI-00431 |
| MNDR | hsa-let-7a-5p | Lymphoma non-hodgkin | MNDR-E-MI-00432 |
| MNDR | hsa-let-7a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-00433 |
| MNDR | hsa-let-7a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-00434 |
| MNDR | hsa-let-7a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-00435 |
| MNDR | hsa-let-7a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-00436 |
| MNDR | hsa-let-7a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-00437 |
| MNDR | hsa-let-7a-5p | Breast cancer luminal | MNDR-E-MI-00438 |
| MNDR | hsa-let-7a-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-00439 |
| MNDR | hsa-let-7a-5p | Lupus nephritis | MNDR-E-MI-00440 |
| MNDR | hsa-let-7a-5p | Prostate cancer | MNDR-E-MI-00441 |
| MNDR | hsa-let-7a-5p | Chronic lymphocytic leukemia | MNDR-E-MI-00442 |
| MNDR | hsa-let-7a-5p | Gastric cancer | MNDR-E-MI-00443 |
| MNDR | hsa-let-7a-5p | Gastric lymphoma | MNDR-E-MI-00444 |
| MNDR | hsa-let-7a-5p | Alzheimer disease | MNDR-E-MI-00445 |
| MNDR | hsa-let-7a-5p | Intracranial aneurysm | MNDR-E-MI-00446 |
| MNDR | hsa-let-7a-5p | Sarcoma | MNDR-E-MI-00447 |
| MNDR | hsa-let-7a-5p | Dysautonomia familial | MNDR-E-MI-00448 |
| MNDR | hsa-let-7a-5p | Malaria | MNDR-E-MI-00449 |
| MNDR | hsa-let-7a-5p | Leukemia | MNDR-E-MI-00450 |
| MNDR | hsa-let-7a-5p | Huntington disease | MNDR-E-MI-00451 |
| MNDR | hsa-let-7a-5p | Cardiovascular disease | MNDR-E-MI-00452 |
| MNDR | hsa-let-7a-5p | Carotid stenosis | MNDR-E-MI-00453 |
| MNDR | hsa-let-7a-5p | Moyamoya disease | MNDR-E-MI-00454 |
| MNDR | hsa-let-7a-5p | Uterine leiomyoma | MNDR-E-MI-00455 |
| MNDR | hsa-let-7a-5p | Lung cancer | MNDR-E-MI-00456 |
| MNDR | hsa-let-7a-5p | Metabolic syndrome x | MNDR-E-MI-00457 |
| MNDR | hsa-let-7a-5p | Parkinson disease | MNDR-E-MI-00458 |
| MNDR | hsa-let-7a-5p | Niemann-pick disease | MNDR-E-MI-00459 |
| MNDR | hsa-let-7a-5p | Colon carcinoma | MNDR-E-MI-00460 |
| MNDR | hsa-let-7a-5p | Breast cancer | MNDR-E-MI-00461 |
| MNDR | hsa-let-7a-5p | Squamous cell carcinoma | MNDR-E-MI-00462 |
| MNDR | hsa-let-7a-5p | Pancreatic cancer | MNDR-E-MI-00463 |
| MNDR | hsa-let-7a-5p | Malignant melanoma | MNDR-E-MI-00464 |
| MNDR | hsa-let-7a-5p | Lesch-nyhan syndrome | MNDR-E-MI-00465 |
| MNDR | hsa-let-7a-5p | Nephroblastoma | MNDR-E-MI-00466 |
| MNDR | hsa-let-7a-5p | Colon cancer | MNDR-E-MI-00467 |
| MNDR | hsa-let-7a-5p | Colon adenocarcinoma | MNDR-E-MI-00468 |
| MNDR | hsa-let-7a-5p | Multiple sclerosis | MNDR-E-MI-00469 |
| MNDR | hsa-let-7a-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-00470 |
| MNDR | hsa-let-7a-5p | Familial ovarian cancer | MNDR-E-MI-00471 |
| MNDR | hsa-let-7a-5p | Prostate adenocarcinoma | MNDR-E-MI-00472 |
| MNDR | hsa-let-7a-5p | Laryngeal cancer | MNDR-E-MI-00473 |
| MNDR | hsa-let-7a-5p | Laryngeal carcinoma | MNDR-E-MI-00474 |
| MNDR | hsa-let-7a-5p | Myoma | MNDR-E-MI-00475 |
| MNDR | hsa-let-7a-5p | Glioblastoma | MNDR-E-MI-00476 |
| MNDR | hsa-let-7a-5p | Glioma | MNDR-E-MI-00477 |
| MNDR | hsa-let-7a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-00478 |
| MNDR | hsa-let-7a-5p | Nemaline myopathy | MNDR-E-MI-00479 |
| MNDR | hsa-let-7a-5p | Chordoma | MNDR-E-MI-00480 |
| MNDR | hsa-let-7a-5p | Lipoma | MNDR-E-MI-00481 |
| MNDR | hsa-let-7a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-00482 |
| MNDR | hsa-let-7a-5p | Temporal lobe epilepsy | MNDR-E-MI-00483 |
| MNDR | hsa-let-7a-5p | Osteosarcoma | MNDR-E-MI-00484 |
| MNDR | hsa-let-7a-5p | Ewing sarcoma | MNDR-E-MI-00485 |
| MNDR | hsa-let-7a-5p | Chondrosarcoma | MNDR-E-MI-00486 |
| MNDR | hsa-let-7a-5p | Liposarcoma | MNDR-E-MI-00487 |
| MNDR | hsa-let-7a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-00488 |
| MNDR | hsa-let-7a-5p | Lafora disease | MNDR-E-MI-00489 |
| MNDR | hsa-let-7a-5p | Liver cancer | MNDR-E-MI-00490 |
| MNDR | hsa-let-7a-5p | Pituitary adenoma | MNDR-E-MI-00491 |
| MNDR | hsa-let-7a-5p | Lung squamous cell carcinoma | MNDR-E-MI-00492 |
| MNDR | hsa-let-7a-5p | Carcinoma lung non-small-cell | MNDR-E-MI-00493 |
| MNDR | hsa-let-7a-5p | Lung adenocarcinoma | MNDR-E-MI-00494 |
| MNDR | hsa-let-7a-5p | Adrenocortical cancer | MNDR-E-MI-00495 |
| MNDR | hsa-let-7a-5p | Thyroid follicular adenoma and carcinoma | MNDR-E-MI-00496 |
| MNDR | hsa-let-7a-5p | Tuberculosis | MNDR-E-MI-00497 |
| MNDR | hsa-let-7a-5p | Scleroderma | MNDR-E-MI-00498 |
| MNDR | hsa-let-7a-5p | Myasthenia gravis | MNDR-E-MI-00499 |
| MNDR | hsa-let-7a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-00500 |
| MNDR | hsa-let-7a-5p | Carcinoma renal cell | MNDR-E-MI-00501 |
| MNDR | hsa-let-7a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-00502 |
| MNDR | hsa-let-7a-5p | Biliary tract cancer | MNDR-E-MI-00503 |
| MNDR | hsa-let-7a-5p | Cholangiocarcinoma | MNDR-E-MI-00504 |
| MNDR | hsa-let-7a-5p | Esophageal cancer | MNDR-E-MI-00505 |
| MNDR | hsa-let-7a-5p | Liver cirrhosis | MNDR-E-MI-00506 |
| MNDR | hsa-let-7a-5p | Synovial sarcoma | MNDR-E-MI-00507 |
| MNDR | hsa-let-7a-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-00508 |
| MNDR | hsa-let-7a-5p | Fibromyalgia | MNDR-E-MI-00509 |
| MNDR | hsa-let-7a-5p | Encephalomyelitis | MNDR-E-MI-00510 |
| MNDR | hsa-let-7a-5p | Pulmonary arterial hypertension | MNDR-E-MI-00511 |
| MNDR | hsa-let-7a-5p | Adenoma | MNDR-E-MI-00512 |
| MNDR | hsa-let-7a-5p | Early hepatocellular carcinoma | MNDR-E-MI-00513 |
| MNDR | hsa-let-7a-5p | Embryonal cancer | MNDR-E-MI-00514 |
| MNDR | hsa-let-7a-5p | Familiar ovarian carcinoma | MNDR-E-MI-00515 |
| MNDR | hsa-let-7a-5p | B-cell lymphoma | MNDR-E-MI-00516 |
| MNDR | hsa-let-7a-5p | Rheumatoid arthritis | MNDR-E-MI-00517 |
| MNDR | hsa-let-7a-5p | T-cell leukemia | MNDR-E-MI-00518 |
| MNDR | hsa-let-7a-5p | Malignant pleural mesothelioma | MNDR-E-MI-00519 |
| MNDR | hsa-let-7a-5p | Retinoblastoma | MNDR-E-MI-00520 |
| MNDR | hsa-let-7a-5p | Neuroblastoma | MNDR-E-MI-00521 |
| MNDR | hsa-let-7a-5p | Hodgkin lymphoma | MNDR-E-MI-00522 |
| MNDR | hsa-let-7a-5p | Burkitt lymphoma | MNDR-E-MI-00523 |
| MNDR | hsa-let-7a-5p | Neuromyelitis optica | MNDR-E-MI-00524 |
| MNDR | hsa-let-7a-5p | Acute myeloid leukemia | MNDR-E-MI-00525 |
| MNDR | hsa-let-7a-5p | Colorectal cancer | MNDR-E-MI-00526 |
| MNDR | hsa-let-7a-5p | Nasopharyngeal carcinoma | MNDR-E-MI-00527 |
| MNDR | hsa-let-7a-5p | Nasopharynx carcinoma | MNDR-E-MI-00528 |
| MNDR | hsa-let-7a-5p | Multiple myeloma | MNDR-E-MI-00529 |
| MNDR | hsa-let-7a-5p | Ovarian epithelial cancer | MNDR-E-MI-00530 |
| MNDR | hsa-let-7a-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-00531 |
| MNDR | hsa-let-7a-5p | Hamartoma | MNDR-E-MI-00532 |
| MNDR | hsa-let-7a-5p | Nasopharyngeal cancer | MNDR-E-MI-00533 |
| MNDR | hsa-let-7a-5p | Prostatic neoplasms | MNDR-E-MI-00534 |
| MNDR | hsa-let-7a-5p | Sleep deprivation | MNDR-E-MI-00535 |
| MNDR | hsa-let-7a-5p | Aids dementia complex | MNDR-E-MI-00536 |
| MNDR | hsa-let-7a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-00537 |
| MNDR | hsa-let-7a-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-00538 |
| MNDR | hsa-let-7a-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-00539 |
| MNDR | hsa-let-7a-5p | Pituitary acth hypersecretion | MNDR-E-MI-00540 |
| MNDR | hsa-let-7a-5p | Chronic pain | MNDR-E-MI-00541 |
| MNDR | hsa-let-7a-5p | Stroke lacunar | MNDR-E-MI-00542 |
| MNDR | hsa-let-7a-5p | Breast cancer her3+ negative | MNDR-E-MI-00543 |
| MNDR | hsa-let-7a-5p | High grade dysplastic nodule | MNDR-E-MI-00544 |
| MNDR | hsa-let-7a-5p | Malignant cholangiocyte | MNDR-E-MI-00545 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR1B | Homo sapiens | RR00038908 |
TOP